| Year |
Citation |
Score |
| 2015 |
Qin T, Si J, Raynal NJ, Wang X, Gharibyan V, Ahmed S, Hu X, Jin C, Lu Y, Shu J, Estecio MR, Jelinek J, Issa JP. Epigenetic synergy between decitabine and platinum derivatives. Clinical Epigenetics. 7: 97. PMID 26366234 DOI: 10.1186/S13148-015-0131-Z |
0.71 |
|
| 2012 |
Zhang Y, Shu J, Si J, Shen L, Estecio MR, Issa JP. Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island. Nucleic Acids Research. 40: 7257-68. PMID 22600741 DOI: 10.1093/Nar/Gks429 |
0.772 |
|
| 2012 |
Raynal NJ, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, Estécio MR, Issa JP. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Research. 72: 1170-81. PMID 22219169 DOI: 10.1158/0008-5472.Can-11-3248 |
0.703 |
|
| 2011 |
Qin T, Castoro R, El Ahdab S, Jelinek J, Wang X, Si J, Shu J, He R, Zhang N, Chung W, Kantarjian HM, Issa JP. Mechanisms of resistance to decitabine in the myelodysplastic syndrome. Plos One. 6: e23372. PMID 21858090 DOI: 10.1371/Journal.Pone.0023372 |
0.677 |
|
| 2010 |
Si J, Boumber YA, Shu J, Qin T, Ahmed S, He R, Jelinek J, Issa JP. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Research. 70: 6968-77. PMID 20713525 DOI: 10.1158/0008-5472.Can-09-4474 |
0.668 |
|
| 2010 |
Yan Z, Shu J, Si J, Qin T, Estecio MR, Issa J. Abstract LB-84: DNA methylation centers in CpG-island promoters are context-specific Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-84 |
0.776 |
|
| 2009 |
Qin T, Jelinek J, Si J, Shu J, Issa JP. Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines. Blood. 113: 659-67. PMID 18931345 DOI: 10.1182/Blood-2008-02-140038 |
0.698 |
|
| Show low-probability matches. |